OPA3 Supports Pancreatic Tumor Growth Through Context-Dependent Metabolic and Hypoxic Adaptation
Background: Optic atrophy protein 3 (OPA3) regulates mitochondrial function, but its contribution to cancer progression and adaptation to hypoxic tumor microenvironments remains incompletely understood. Methods: We examined OPA3 expression across 31 cancer types and investigated its function using CRISPR/Cas9 knockout in five cancer cell lines with different KRAS backgrounds. Proliferation, clonogenic growth, mitochondrial metabolism, and ATP production were evaluated in vitro. Pancreatic cancer xenografts, hypoxia experiments, and spatial transcriptomic analyses were used to assess tumor growth and HIF-1α-associated responses. Results: OPA3 expression varied across cancer types. OPA3 knockout preferentially impaired proliferation and clonogenic growth in the KRAS-mutant cell lines examined, with reduced mitochondrial respiration and ATP production observed in PANC-1 cells. Despite limited effects on KRAS-wild-type BxPC-3 cells in vitro, OPA3 depletion suppressed both PANC-1 and BxPC-3 xenograft growth. Under prolonged hypoxia, OPA3-deficient cells exhibited reduced HIF-1α protein accumulation and impaired clonogenic growth. Spatial transcriptomic analyses identified a positive association between OPA3 and HIF1A expression in pancreatic tumor-associated tissues. However, these observations do not establish direct HIF-1α stabilization or a causal relationship in human tumors. Conclusions: OPA3 supports pancreatic tumor growth through context-dependent processes associated with mitochondrial metabolism and hypoxic adaptation. Its effects extend beyond KRAS mutation status in xenograft models, although the underlying mechanisms require further validation. These findings identify OPA3 as a candidate regulator of tumor-microenvironment adaptation rather than an established therapeutic target.
Authors
- Christophe Glorieux (ORCID: https://orcid.org/0000-0003-1944-611X)
- Zichen Qiu (ORCID: https://orcid.org/0000-0003-2536-8816)
- Rūta Steponaitienė (ORCID: https://orcid.org/0000-0001-6774-6657)
- Ning Meng (ORCID: https://orcid.org/0000-0003-1308-9094)
- Wenwen Ding (ORCID: https://orcid.org/0009-0002-6153-2126)
Publication Details
- Journal
- Cancer Biome and Targeted Therapy
- Published
- 2026-11-14
- DOI
- https://doi.org/10.66505/cbtt.v1i4.72
- Primary Topic
- Cancer, Hypoxia, and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.00